NHS expands RSV vaccination to vulnerable adults, while advances in ML-driven disease prediction, cardiac imaging, and CAR T-cell therapy for skin diseases reshape treatment landscapes across multiple conditions.

NHS England confirmed that all adults aged 65-74 with chronic respiratory conditions or weakened immune systems will be offered the RSV vaccine starting September, expanding protection against respiratory syncytial virus in vulnerable populations.

Advanced machine learning models have successfully identified shared risk factors and predictors for disease onset in patients with epilepsy and depression, offering potential for early intervention and personalized prevention strategies.

A novel 5D MRI technique using gadolinium enhancement significantly reduces scan time for whole-heart imaging in patients with congenital heart disease, improving diagnostic efficiency and patient experience.

CAR T-cell therapy is anticipated to gain regulatory approval for treating autoimmune skin diseases as soon as this year, promising rapid expansion across dermatological applications currently limited by conventional treatments.

Traumatic brain injury shows bidirectional associations with stroke, dementia, epilepsy, and Parkinson's disease, suggesting that TBI patients require long-term neurological monitoring and those with these conditions face elevated TBI risks.

Nearly 1 in 10 patients with primary biliary cholangitis develop chronic kidney disease, which significantly increases mortality risk and highlights the need for integrated screening and management of kidney function in this population.

Merkel cell carcinoma patients experience substantially higher mortality rates, more hospitalizations, and greater comorbidity burden compared to matched control groups and other cancer cohorts, underscoring the disease's clinical severity.

Topical steroid withdrawal remains a controversial treatment approach in eczema management, with medical professionals emphasizing compassionate, patient-centered care that supports informed decision-making regarding discontinuation.